---

4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole 9CI

Synonyms

WLN: T B656 EN HM EUT&&J F JO1
Hayward: 6RRR(OM)RY5NHY(=)LM=NLLY5Y

Usdin & Efron 1979

CA Reg. No.: 000304212 [304-21-2]
NIOSH No.: UU9800000

Southon & Buckingham 1989

Legal Status: Harmaline lacks abuse potential and is not a controlled substance. According to Ott 1996, it appears to be "watched".

Harmaline was discovered on 22 December, 1837 by Fr. Göbel; isolating it (contaminated with harmine) from Peganum harmala seeds. See Göbel 1844


Structure, physical properties & assays


Dosage, pharmacology, toxicology and metabolic studies


Reported Occurrences of harmaline:


Harmaline entry was largely drawn from:
CRC 1980-1981 CRC Handbook of Chemistry and Physics. 61st edition. Entry No. 7470, page C-347.
Merck Index 1976 Merck Index Ninth Edition. Entry #4468, page 601.
Ott 1993 Pharmacotheon. Entry # 17, page 438 [Merck Index 11: 4528]
Shulgin & Shulgin 1997 TIHKAL. Entry #13, pages 444-454.
Southon & Buckingham 1989 Dictionary of Alkaloids. Entry H-00034, page 487.
Usdin & Efron 1979 Psychotropic Drugs and Related Compounds. Entry #342, pages 116 and 493-494.

A complete listing can be found in the reference list

See Beilstein B23², 345
Beilstein 4. Aufl. 23, E II 345